Jackie Fairley has more than 30 years of experience in the pharmaceutical and biotechnology industries working in senior commercial and management roles with companies including CSL and Faulding (acquired by Pfizer).
Jackie is a non-executive director of Calvary Health Care, and Mirrabooka Investments and an advisor to global Private Equity firm EQT. Jackie served as Chief Executive Officer and Managing Director of ASX-listed Starpharma Pty Ltd from 2006 to 2024. She is past Chair of Victorian Trade and Investment Advisory Board and was an advisor to the Carnegie Venture Capital for more than 10 years. Jackie is also a past member of the Federal Government’s Commonwealth Science Council, Pharmaceutical Industry Working Group and several other Ministerial advisory groups spanning pharmaceuticals, economic development, and innovation.